Disc Medicine (IRON) Retained Earnings (2020 - 2026)
Disc Medicine (IRON) reported Retained Earnings of -$573.7 million for Q1 2026, down 72.75% year-over-year from -$2.1 billion in Q1 2025, and down 59549.74% quarter-over-quarter from $965000.0 in Q4 2025.
Disc Medicine (IRON) Retained Earnings (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Retained Earnings data on file, last reported at -$573.7 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$573.7 million, down 72.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$573.7 million (down 72.75% YoY), and the FY2025 annual result was $965000.0, up 233.91% from the prior year.
- Retained Earnings declined to -$573.7 million in Q1 2026 per IRON's latest filing, from $965000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $965000.0 in Q4 2025 and troughed at -$573.7 million in Q1 2026.
- A 5-year average of -$212.9 million and a median of -$203.5 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 233.91% in 2025 and fell as far as 645400.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$112.2 million in 2022, then sank by 47.13% to -$165.1 million in 2023, then surged by 100.18% to $289000.0 in 2024, then soared by 233.91% to $965000.0 in 2025, then tumbled by 59549.74% to -$573.7 million in 2026.
- Business Quant data shows IRON's Retained Earnings at -$573.7 million in Q1 2026, $965000.0 in Q4 2025, and -$449.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | -573.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -573.69 Mn |
| Dec 31, 2025 | 965,000.00 |
| Sep 30, 2025 | -449.70 Mn |
| Jun 30, 2025 | -387.30 Mn |
| Mar 31, 2025 | -332.09 Mn |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | -268.50 Mn |
| Jun 30, 2024 | -60,000.00 |
| Mar 31, 2024 | -215.60 Mn |
| Sep 30, 2023 | -165.10 Mn |
| Jun 30, 2023 | -150.90 Mn |
| Mar 31, 2023 | -135.00 Mn |
| Dec 31, 2022 | -112.22 Mn |
| Sep 30, 2022 | -210.29 Mn |
| Jun 30, 2022 | -207.01 Mn |
| Mar 31, 2022 | -199.92 Mn |
| Dec 31, 2021 | -65.39 Mn |
| Sep 30, 2021 | -166.87 Mn |
| Jun 30, 2021 | -148.32 Mn |
| Mar 31, 2021 | -131.87 Mn |